Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectives
Vaccines are essential public health tools with a favorable safety profile and prophylactic
effectiveness that have historically played significant roles in reducing infectious disease …
effectiveness that have historically played significant roles in reducing infectious disease …
Vaccine-associated hypersensitivity
MM McNeil, F DeStefano - Journal of Allergy and Clinical Immunology, 2018 - Elsevier
Information for Category 1 CME Credit Credit can now be obtained, free for a limited time, by
reading the review articles in this issue. Please note the following instructions. Method of …
reading the review articles in this issue. Please note the following instructions. Method of …
Risk of anaphylaxis after vaccination in children and adults
MM McNeil, ES Weintraub, J Duffy, L Sukumaran… - Journal of allergy and …, 2016 - Elsevier
Background Anaphylaxis is a potentially life-threatening allergic reaction. The risk of
anaphylaxis after vaccination has not been well described in adults or with newer vaccines …
anaphylaxis after vaccination has not been well described in adults or with newer vaccines …
[HTML][HTML] Evidence-based clinical guidelines for immigrants and refugees
Health: Deborah Assayag, Elizabeth Barnett, Jennifer Blake, Beverly Brockest, Giovani
Burgos, Glenn Campbell, Andrea Chambers, Angie Chan, Maryann Cheetham, Walter …
Burgos, Glenn Campbell, Andrea Chambers, Angie Chan, Maryann Cheetham, Walter …
Vaccination and allergy: EAACI position paper, practical aspects
L Nilsson, K Brockow, J Alm, V Cardona… - Pediatric Allergy and …, 2017 - Wiley Online Library
Immunization is highly effective in preventing infectious diseases and therefore an
indispensable public health measure. Allergic patients deserve access to the same publicly …
indispensable public health measure. Allergic patients deserve access to the same publicly …
Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink
J Gee, A Naleway, I Shui, J Baggs, R Yin, R Li… - Vaccine, 2011 - Elsevier
BACKGROUND: In 7 large managed care organizations (MCOs), we performed a post-
licensure safety assessment of quadrivalent human papillomavirus vaccine (HPV4) among 9 …
licensure safety assessment of quadrivalent human papillomavirus vaccine (HPV4) among 9 …
Anaphylaxis: recent advances in assessment and treatment
FER Simons - Journal of Allergy and Clinical Immunology, 2009 - Elsevier
The incidence rate of anaphylaxis is increasing, particularly during the first 2 decades of life.
Common triggers include foods, medications, and insect stings. Clinical diagnosis is based …
Common triggers include foods, medications, and insect stings. Clinical diagnosis is based …
[HTML][HTML] General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)
AT Kroger, WL Atkinson, EK Marcuse, LK Pickering - MMWR Recomm Rep, 2006 - cdc.gov
This report is a revision of the General Recommendations on Immunization and updates the
2006 statement by the Advisory Committee on Immunization Practices (ACIP)(CDC. General …
2006 statement by the Advisory Committee on Immunization Practices (ACIP)(CDC. General …
[HTML][HTML] General recommendations on immunization
AT Kroger, CV Sumaya, LK Pickering, WL Atkinson - MMWR Recomm Rep, 2011 - cdc.gov
This report is a revision of General Recommendations on Immunization and updates the
2002 statement by the Advisory Committee on Immunization Practices (ACIP)(CDC. General …
2002 statement by the Advisory Committee on Immunization Practices (ACIP)(CDC. General …
Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines
S Black, J Eskola, CA Siegrist, N Halsey, N MacDonald… - The Lancet, 2009 - thelancet.com
Because of the advent of a new influenza A H1N1 strain, many countries have begun mass
immunisation programmes. Awareness of the background rates of possible adverse events …
immunisation programmes. Awareness of the background rates of possible adverse events …